Search

Your search keyword '"BLOOD substitutes"' showing total 250 results

Search Constraints

Start Over You searched for: Descriptor "BLOOD substitutes" Remove constraint Descriptor: "BLOOD substitutes" Publisher taylor & francis ltd Remove constraint Publisher: taylor & francis ltd
250 results on '"BLOOD substitutes"'

Search Results

1. Qualitative and quantitative status of cytochrome P450s after the administration of a liposomal platelet substitute in rat liver.

2. Corrosion behaviour of electroless NiP coating in artificial blood plasma.

3. Development of nanobiosensor for therapeutic drug monitoring in personalized cancer treatment approach.

4. Recent advances in microfluidic technology of arterial thrombosis investigations.

5. A lead-free flexible polymer/ceramic based nanocomposites thin film for electronic application.

6. Preparation and exchange transfusion effect of a double polymerization human umbilical cord haemoglobin of red blood cell substitute.

7. Recent advances in micro-sized oxygen carriers inspired by red blood cells.

8. Optimization of sampling conditions to minimize sampling errors of both PM2.5 mass and its semi-volatile inorganic ion concentrations.

9. A filtration medium replacement method that increases the efficiency of immunofluorescence staining of oocytes.

10. Understanding Grain Growth Mechanism in Vacuum Evaporated CdTe Thin Films by Different Halide Treatments: An Evolution of Ion Size Impact on Physical Properties for Solar Cell Applications.

11. Development and application of a sensitive, disposable and low-cost electrochemical sensing platform for an antimalarial drug: amodiaquine based on poly(calcein)-modified pencil graphite electrode.

12. The role of artificial cells in the fight against COVID-19: deliver vaccine, hemoperfusion removes toxic cytokines, nanobiotherapeutics lower free radicals and pCO2 and replenish blood supply.

13. Lung injury following cardiopulmonary bypass: a clinical update.

14. A systematic multidisciplinary initiative may reduce the need for blood products in patients with abnormally invasive placenta.

15. Validating a simulation model for laser-induced thermotherapy using MR thermometry.

16. Capsules from synthetic diblock-peptides as potential artificial oxygen carriers.

17. Blood concentrations of synthetic cathinones.

18. Development of indigenous personal protective equipment coverall by CSIR-NAL.

19. Cellular attachment behavior on biodegradable polymer surface immobilizing endothelial cell-specific peptide.

20. Urease immobilized electrospun PVA/chitosan nanofibers with improved stability and reusability characteristics: an application for removal of urea from artificial blood serum.

21. Synthesis and characterisation of aqueous haemoglobin-based microcapsules coated by genipin-cross-linked albumin.

22. Dopamine biosensor based on screen-printed electrode modified with reduced graphene oxide, polyneutral red and gold nanoparticle.

23. Development of choline biosensor using toluidine blue O as mediator.

24. Prolonged functional life span of artificial red cells in blood circulation by repeated methylene blue injections.

25. Physicochemical properties and oxygen affinity of glutaraldehyde polymerized crocodile hemoglobin: the new alternative hemoglobin source for hemoglobin-based oxygen carriers.

26. ARTIFICIAL CELL evolves into nanomedicine, biotherapeutics, blood substitutes, drug delivery, enzyme/gene therapy, cancer therapy, cell/stem cell therapy, nanoparticles, liposomes, bioencapsulation, replicating synthetic cells, cell encapsulation/scaffold, biosorbent/immunosorbent haemoperfusion/plasmapheresis, regenerative medicine, encapsulated microbe, nanobiotechnology, nanotechnology

27. A case of mediastinitis with an exposed artificial blood vessel that was associated with right ventricular wall damage during treatment.

28. Development of tri-layer breathable fluid barrier nonwoven fabrics for surgical gown applications.

29. Advancement of platelet-inspired nanomedicine.

30. Long term safety and immunological effects of a nanobiotherapeutic, bovine poly-[hemoglobin-catalase-superoxide dismutase-carbonic anhydrase], after four weekly 5% blood volume top-loading followed by a challenge of 30% exchange transfusion.

31. In vivo evaluation of electron mediators for the reduction of methemoglobin encapsulated in liposomes using electron energies produced by red blood cell glycolysis.

32. Increasing the stability of Lumbricus terrestris erythrocruorin via poly(acrylic acid) conjugation.

33. Glutaraldehyde inactivation of enveloped DNA viruses in the preparation of haemoglobin-based oxygen carriers.

34. Prolonging the shelf life of Lumbricus terrestris erythrocruorin for use as a novel blood substitute.

35. Ferulic acid modification enhances the anti-oxidation activity of natural Hb in vitro.

37. Hemoglobin extravasation in the brain of rats exchange-transfused with hemoglobin-based oxygen carriers.

38. Functionality of albumin-derived perfluorocarbon-based artificial oxygen carriers in the Langendorff-heart.

39. Zero-link polymerized hemoglobin (OxyVita Hb) stabilizes the heme environment: potential for lowering vascular oxidative stress.

40. Copolymerization of recombinant Phascolopsis gouldii hemerythrin with human serum albumin for use in blood substitutes.

41. Acute kidney function and morphology following topload administration of recombinant hemoglobin solution.

42. Design Considerations for the Implementation of Artificial Fluids as Blood Substitutes for Educational and Training Use in the Forensic Sciences.

43. Processing of ferulic acid modified hemoglobin.

44. Temperature stability of Poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] in the form of a solution or in the lyophilized form during storage at −80 °C, 4 °C, 25 °C and 37 °C or pasteurization at 70 °C

45. Statement of retraction: Influence of various lipid core on characteristics of SLNs designed for topical delivery of fluconazole against cutaneous candidiasis.

46. On acid-base effects of albumin.

47. Extraction of superoxide dismutase, catalase, and carbonic anhydrase from stroma-free red blood cell hemolysate for the preparation of the nanobiotechnological complex of polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase.

48. Control of oxidative reactions of hemoglobin in the design of blood substitutes: role of the Vc, NAC, TEMPO and their reductant system.

49. Artificial oxygen carriers based on perfluorodecalin-filled poly( n-butyl-cyanoacrylate) nanocapsules.

50. Hemoglobin-albumin cross-linking with disuccinimidyl suberate (DSS) and/or glutaraldehyde for blood substitutes.

Catalog

Books, media, physical & digital resources